BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/16/2026 10:03:33 AM | Browse: 6 | Download: 2
Publication Name World Journal of Diabetes
Manuscript ID 126228
DOI 10.4239/wjd.126228
Country China
Category Endocrinology & Metabolism
Manuscript Type Observational Study
Article Title Lipid-lowering therapy disparities between peripheral artery disease and cardiocerebrovascular disease in type 2 diabetes: A multicenter cross-sectional study
Manuscript Source Unsolicited Manuscript
All Author List Xiao-Qi Ye, Yan Li, Bing-Xue Wang, Li-Hong Chen, Ai-Hong Wang, Zhang-Rong Xu, Li-Nong Ji and Xing-Wu Ran
Funding Agency and Grant Number
Funding Agency Grant Number
Postdoctoral Fellowship Program of CPSF GZC20241152
the 1.3.5 Project for Disciplines of Excellence, West China Hospital of Sichuan University ZYGD24005
the Open Research Fund Program of the Shanghai Key Laboratory of Diabetes Mellitus SHKLD-KF-2305
the Science and Technology Cooperation between Sichuan University and Zigong City 2024CDZG-22
the Guangxi Key Research and Development Project of Science and Technology Plan Guikexiang AB25069067
Corresponding Author Xing-Wu Ran, MD, Department of Endocrinology and Metabolism, Diabetic Foot Care Center, Innovation Research Center for Diabetic Foot, West China Hospital of Sichuan University, No. 37 Guoxue Lane, Chengdu 610041, Sichuan Province, China. ranxingwu@163.com
Key Words Diabetes mellitus, type 2; Peripheral arterial disease; Coronary artery disease; Cerebrovascular disease; Lipid-lowering therapy; Cross-sectional studies
Core Tip In this multicenter, hospital-based, cross-sectional study of 8941 Chinese adults with type 2 diabetes at elevated atherosclerotic cardiovascular disease (ASCVD) risk, peripheral artery disease (PAD) alone was associated with less frequent lipid-lowering therapy than cardiocerebrovascular disease alone, despite a similar dyslipidemia prevalence. These findings suggest that PAD is underrecognized in routine diabetes care and should trigger the same systematic lipid-management attention as other ASCVD manifestations.
Citation Ye XQ, Li Y, Wang BX, Chen LH, Wang AH, Xu ZR, Ji LN, Ran XW. Lipid-lowering therapy disparities between peripheral artery disease and cardiocerebrovascular disease in type 2 diabetes: A multicenter cross-sectional study. World J Diabetes 2026; In press
PDF 126228-in-press.pdf
Received
2026-08-10 01:51
Peer-Review Started
2026-08-10 07:13
First Decision by Editorial Office Director
Return for Revision
2026-08-28 07:29
Revised
2026-09-21 12:42
Publication Fee Transferred
2026-10-27 11:22
Second Decision by Editor
2026-11-09 02:06
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-11-16 10:03
Articles in Press
2026-11-16 10:03
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-9358 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com